In this review, we describe the involvement of VEGFR1-TK signaling in pulmonary fibrosis by using a bleomycin (BLM)-induced pulmonary fibrosis model and discussed the possibility of selective VEGFR1-TK inhibitor in future treatment. This evidence concerns the gene FLT1 and pulmonary fibrosis.